Form 4: BeiGene's President and COO Xiaobin Wu Executes Stock Options and Sells Shares

Xiaobin Wu, President, COO & GM China of BeiGene, Ltd., exercised stock options and sold American Depositary Shares (ADS) between February 18 and February 20, 2025, according to a recent SEC filing.

Summary

• Xiaobin Wu, President, COO & GM China of BeiGene, Ltd., engaged in transactions involving the company's stock.
• On February 18, 2025, Wu exercised options to acquire 398,502 ordinary shares and sold 19,576 ADSs at a weighted average price of $240.3067, 7,919 ADSs at $241.2626 and 3,159 ADSs at $242.0794.
• On February 20, 2025, Wu exercised options to acquire 276,471 ordinary shares and sold 21,267 ADSs at a weighted average price of $240.0674.
• These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 13, 2024.
• Following these transactions, Wu directly owns 1,071,327 ordinary shares and varying amounts of American Depositary Shares.
• Wu also has an indirect economic interest in RMB Shares through an employee participation program, but disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document primarily reports transactions by an officer under a pre-existing trading plan. It doesn't inherently indicate positive or negative performance for the company.

Industry Context

Insider transactions are common, and the use of a 10b5-1 plan suggests the sales were pre-planned and not based on current inside information.

Comparison to Industry Standards

• It's common for executives at publicly traded companies, including those in the biotechnology sector like BeiGene, to have compensation packages that include stock options.
• The exercise of these options and subsequent sale of shares is a typical way for executives to realize some of the value of their equity compensation.
• The use of a Rule 10b5-1 trading plan is a standard practice to avoid accusations of insider trading, as it demonstrates that the sales were planned in advance.

Key Dates

Keywords

BeiGene, Xiaobin Wu, stock options, ADS, Rule 10b5-1, insider trading, RMB Shares, employee participation plan